Bioavailability of Tebipenem (SPR994) Crushed Tablet
Status:
Not yet recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to measure the amount of the antibiotic, tebipenem (SPR994) that
is bioavailable after crushing the tablet and administering through a feeding tube with and
without tube feeds.